Side effects at higher Wegovy doses: separating myth from what the evidence shows

The biggest myth: that side effects keep getting worse the higher you go

Most people starting Wegovy expect a straight line, more dose equals more side effects, indefinitely. The clinical evidence does not support that. In the STEP programme trials, gastrointestinal side effects were most pronounced in the first weeks of treatment and after each dose increase, but the peak was not at the highest maintenance dose; it was at the transition points. Once the body acclimatises to a given dose, side effects often settle considerably before the next increase is introduced.

This matters for how you read the titration schedule. The 0.25mg starting dose exists precisely to let your system adjust before anything therapeutic is on board. Moving up through 0.5mg, 1mg, 1.7mg and 2.4mg, each step typically brings a short window of renewed GI sensitivity, nausea, loose stools, a loss of appetite that can go further than intended. Most of that settles. The full Wegovy dose schedule explains each step in more detail.

If you are considering the newer 7.2mg maintenance dose, the pattern holds: trial data reported around 20.7% average weight loss at 7.2mg, but the side-effect profile is qualitatively similar to 2.4mg, not a different category of risk. Higher intensity is possible, but it is not a step-change in danger for most people. A prescriber's job is to assess whether that next increase is appropriate for you specifically.

What actually changes when the dose goes up: a realistic picture

Each dose increase can temporarily bring back side effects you thought you had left behind. Nausea is the most reported; vomiting is less common but does occur. Constipation affects some people more at higher doses because gastric emptying slows further. Others find the opposite, that diarrhoea becomes more of an issue early after a step-up. Burping, reflux, and a general sensitivity to larger meals are also frequently reported.

Fatigue and headache can accompany the GI picture, particularly in the first few days after an increase. These tend to resolve within a week for most people. Injection-site reactions (redness, mild swelling, itching at the abdomen, thigh or upper arm) remain possible at any dose but are not dose-dependent in the same way GI effects are.

The side effects specific to the 2.4mg maintenance dose are documented separately for people who want the detail at that stage. For context on how lower doses compare, the 1.7mg dose experience is a useful reference point mid-titration, and those moving through the 1mg step can find a detailed look at what to expect at the Wegovy 1mg dose before stepping up further. What the evidence consistently shows is that the first fortnight after each increase is when most people feel it most; the STEP 1 trial, published in the New England Journal of Medicine, documented this pattern across thousands of participants over 68 weeks.

When to get medical help: symptoms that should not wait

Most Wegovy side effects are uncomfortable rather than dangerous. A few are not. Knowing the difference is the most practical thing this page can give you.

Seek urgent medical attention if you experience severe, persistent stomach pain that radiates towards your back, with or without vomiting. This is the warning sign for acute pancreatitis, a serious but infrequent risk that the MHRA specifically highlighted in its January 2026 Drug Safety Update for GLP-1 medicines. Do not wait to see if it passes.

Other situations that warrant prompt medical contact: signs of gallbladder problems (sudden pain in the upper right abdomen, especially after eating), symptoms of severe dehydration from prolonged vomiting or diarrhoea (feeling faint, very dark urine, not passing urine), or any signs of an allergic reaction such as swelling of the face or difficulty breathing. If you have diabetes and are taking other medications alongside Wegovy, low blood sugar is an additional consideration, discuss this with your prescriber before any dose change.

Our prescribers discuss these markers with patients as part of every clinical review. If you are unsure whether a symptom is worth escalating, the safest choice is to check. Side effects can also be reported to the MHRA through the Yellow Card scheme; doing so helps build the national safety record for these medicines.

Managing side effects through the higher doses: what actually helps

There is no single answer that works for everyone, but several approaches have consistent support. Eating smaller meals and avoiding rich or fatty food reduces the gastric-emptying burden. Cold or room-temperature food tends to sit better than hot food during periods of nausea. Staying well-hydrated matters more than people realise, particularly when GI side effects are active, because fluid loss compounds quickly.

The timing of your injection can be adjusted. Some people find injecting at night means the sharpest nausea peak passes during sleep. That is a conversation to have with your prescriber rather than a self-directed change, because timing interacts with other factors.

For people considering higher doses for the first time, our overview of high-dose Wegovy side effects covers the broader picture, and the 7.2mg-specific side-effect detail is available for those titrating to the maximum. The most useful thing a prescriber can do is help you distinguish between side effects that benefit from dose pausing and those that just need time. At nume, our prescribers review every repeat order and are available seven days a week for aftercare questions. Check your eligibility to start that conversation.